Literature DB >> 3693552

Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.

R N Jones1, A L Barry.   

Abstract

Carumonam 30-microgram disk diffusion tests with 342 gram-negative organisms suggested modifying earlier interpretive zone criteria, i.e., a susceptibility zone diameter of greater than or equal to 23 mm (less than or equal to 8.0 micrograms/ml MIC correlate) and a resistance zone diameter of less than or equal to 17 mm (greater than or equal to 32 micrograms/ml MIC correlate). Quality assurance guidelines were determined by multilaboratory investigations. Recommended limits were calculated for the gram-negative quality control organisms only. For Escherichia coli ATCC 25922, the recommended limits are 30 to 36 mm and 0.03 to 0.25 micrograms/ml, and for Pseudomonas aeruginosa ATCC 27853, they are 24 to 32 mm and 1.0 to 4.0 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3693552      PMCID: PMC269457          DOI: 10.1128/jcm.25.11.2243-2246.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.

Authors:  R N Jones; A L Barry; C Thornsberry; P C Fuchs; R R Packer
Journal:  Am J Clin Pathol       Date:  1986-11       Impact factor: 2.493

2.  Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.

Authors:  A L Barry; T L Gavan; R N Jones; L W Ayers; P C Fuchs; E H Gerlach; C Thornsberry
Journal:  Diagn Microbiol Infect Dis       Date:  1987-05       Impact factor: 2.803

3.  Synthesis of sulfazecin-type 2-azetidinones with a carbon substituent at the 4-position.

Authors:  S Kishimoto; M Sendai; S Hashiguchi; M Tomimoto; Y Satoh; T Matsuo; M Kondo; M Ochiai
Journal:  J Antibiot (Tokyo)       Date:  1983-10       Impact factor: 2.649

4.  Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

Authors:  T L Gavan; R N Jones; A L Barry; P C Fuchs; E H Gerlach; J M Matsen; L B Reller; C Thornsberry; L D Thrupp
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

5.  In vitro activity of carumonam.

Authors:  R J Fass; V L Helsel
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.

Authors:  A L Barry; C Thornsberry; R N Jones; T L Gavan
Journal:  Rev Infect Dis       Date:  1985 Nov-Dec

7.  In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.

Authors:  A Imada; M Kondo; K Okonogi; K Yukishige; M Kuno
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

8.  The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Piddock
Journal:  J Antimicrob Chemother       Date:  1985-02       Impact factor: 5.790

9.  Pharmacokinetics of carumonam in patients with renal insufficiency.

Authors:  F Horber; H J Egger; E Weidekamm; U C Dubach; F J Frey; P J Probst; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

10.  Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.

Authors:  E Weidekamm; K Stoeckel; H J Egger; W H Ziegler
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

View more
  1 in total

1.  In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila.

Authors:  P Hohl; A von Graevenitz; J Zollinger-Iten
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.